Skip to main content
. 2018 Nov 12;8(11):110. doi: 10.1038/s41408-018-0138-8

Table 1a.

Analysis of pSTAT3 expression in untreated PTCL tumor biopsies (n = 169)

(A)a
PTCL major subtypes Total N pSTAT3+ % pSTAT3+ (30% cut-off)
PTCL, NOS 59 16 27
Angioimmunoblastic 38 11 29
ALCL (ALK negative) 23 13 57
ALCL (ALK positive) 15 14 93

(A) pSTAT3 was done on the TMA from (n = 59), AITL (n = 38), and ALCL negative (n = 23) and ALCL positive (n = 15) patients by immunohistochemistry (IHC).